Publications

Export 30 results:
Auteur Title Type [ Année(Desc)]
Filtres: Mot-clé is Treatment Outcome  [Enlever les filtres]
2014
Bedford R, Pickles A, Gliga T, Elsabbagh M, Charman T, Johnson MH.  2014.  Additive effects of social and non-social attention during infancy relate to later autism spectrum disorder.. Dev Sci. 17(4):612-20.
Berlim M, Van den Eynde F, Tovar-Perdomo S, Chachamovich E, Zangen A, Turecki G.  2014.  Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.. World J Biol Psychiatry. 15(7):570-8.
Santisteban JA, Stein MA, Bergmame L, Gruber R.  2014.  Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder.. CNS Drugs. 28(9):825-33.
Berlim M, McGirr A, Van den Eynde F, Fleck MPA, Giacobbe P.  2014.  Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis.. J Affect Disord. 159:31-8.
Thaler L, Wilson S, Coelho JS, Antunes JMazanek, Israel M, Steiger H.  2014.  Mandating weekly weight gain in a day treatment program for eating disorders.. Int J Eat Disord. 47(5):500-6.
Blackhall F, Kim D-W, Besse B, Nokihara H, Han J-Y, Wilner KD, Reisman A, Iyer SN, Hirsh V, Shaw AT.  2014.  Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer.. J Thorac Oncol. 9(11):1625-33.
McGirr A, Van den Eynde F, Chachamovich E, Fleck MPA, Berlim M.  2014.  Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.. Neurosci Lett. 563:144-8.
Mamdani F, Berlim M, Beaulieu M-M, Turecki G.  2014.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.. World J Biol Psychiatry. 15(2):135-44.
Berlim M, Van den Eynde F.  2014.  Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials.. Can J Psychiatry. 59(9):487-96.
Berlim M, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ.  2014.  Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials.. Psychol Med. 44(2):225-39.
Ma W, Quirion R.  2014.  Targeting cell surface trafficking of pain-facilitating receptors to treat chronic pain conditions.. Expert Opin Ther Targets. 18(4):459-72.
Brunet A, Thomas É, Saumier D, Ashbaugh AR, Azzoug A, Pitman RK, Orr SP, Tremblay J.  2014.  Trauma reactivation plus propranolol is associated with durably low physiological responding during subsequent script-driven traumatic imagery.. Can J Psychiatry. 59(4):228-32.
2015
Gauthier S, Proaño JVoltaire, Jia J, Froelich L, Vester JChristophe, Doppler E.  2015.  Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials.. Dement Geriatr Cogn Disord. 39(5-6):332-47.
Kedzior KKarolina, Gellersen HMarie, Brachetti AKatharina, Berlim M.  2015.  Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.. J Affect Disord. 187:73-83.
McGirr A, Van den Eynde F, Tovar-Perdomo S, Fleck MPA, Berlim M.  2015.  Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.. J Affect Disord. 173:216-20.
Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.  2015.  Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.. J Alzheimers Dis. 48(2):473-81.
Godlewska BR, Near J, Cowen PJ.  2015.  Neurochemistry of major depression: a study using magnetic resonance spectroscopy.. Psychopharmacology (Berl). 232(3):501-7.
Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji TK, M Chakravarty M, Voineskos AN.  2015.  Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.. Schizophr Res. 169(1-3):69-75.
Hunsberger JG, Chibane FL, Elkahloun AG, Henderson R, Singh R, Lawson J, Cruceanu C, Nagarajan V, Turecki G, Squassina A et al..  2015.  Novel integrative genomic tool for interrogating lithium response in bipolar disorder.. Transl Psychiatry. 5:e504.

Pages